By carrying tumor-specific biomarkers such as CD63, Cav1, circ-CYP24A1, and miR-1180-3p, exosomes enable highly sensitive and specific detection of early-stage cancers and offer insights into disease progression. The gene discussed is CYP24A1; the disease is neoplasm.